Excellos

About:

Excellos is a developer and manufacturer of cell, gene therapies.

Website: https://www.excellos.com

Twitter/X: Excellos_Corp

Top Investors: Vitalant, Telegraph Hill Partners

Description:

Excellos is a developer and manufacturer of cell and gene therapies intended to facilitate the advancement of advanced therapies. The company offers development and clinical manufacturing for CAR-T, tumor-infiltrating lymphocyte therapy, and immunotherapy, enabling clients to realize the potential of these powerful therapeutics and saving patients' lives. They focus on providing cGMP cellular products and services to scientists and physicians working with cell and gene therapies, as well as process development and manufacturing expertise. The mission is to accelerate the development of cellular therapies and enable these powerful medications to reach their full potential, saving lives now and improving lives tomorrow. establishing a new benchmark in the industry.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)excellos.com

Founders:

David Wellis

Number of Employees:

11-50

Last Funding Date:

2024-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai